/stocks — the workspaceLOADING
Wave Life Sciences Ltd. (WVE) is a pharmaceutical preparations company. Piotroski F-Score 2/7. Next earnings projected around 2026-07-29 from WVE's year-over-year reporting pattern (not yet company-confirmed). Fundamentals from SEC filings; prices are end-of-day.
XBRL company facts, SEC EDGAR. TTM = last four reported quarters. Valuation ratios arrive with a price source — we don't fake quotes.
FY ending 2025-12-31 vs 2024-12-31.
A plain-English read on WVE plus an auto-SWOT — built from WVE's SEC filings and market data, every point cited, nothing invented. Educational, not investment advice.
Four AI analysts — a bull, a bear, a risk manager, and a PM — debate WVE using only the SEC-filing and market facts below. Every point cites its evidence; nothing is invented. This is educational research, not investment advice.
Educational only — not financial advice. Data from SEC EDGAR public filings; no live market data is shown. Figures reflect the company's own reported XBRL facts and may lag.
Projected from WVE's own SEC 8-K filing history — the year-over-year reporting pattern (~50% land the exact day, ~90% within a week). No analyst estimates, no scraped calendars, nothing invented. It upgrades to a confirmed date + time the moment WVE files its announcement.
WVE's earnings reaction has been evenly split — 4 up, 4 down across its last 8 reports.
Each figure is one earnings reaction — how much WVE moved from the closing price the day before a report to the close the day after. Based on its last 8 reports.
Earnings reactions have been moderate.
The average is inflated by its most volatile prints (+5.2% and -7.6%).
A more typical earnings reaction has been approximately ±3.5%.
Realized close-to-close history only — no options-implied move, no analyst estimates.
| Reported | Close-to-close |
|---|---|
| 2026-04-28 | +1.6% |
| 2026-02-26 | -4.2% |
| 2026-01-12 | +2.7% |
| 2025-11-10 | -7.6% |
| 2025-07-30 | -2.6% |
| 2025-05-08 | +1.5% |
| 2025-03-04 |
Earnings dates are the company's 8-K Item 2.02 filings (SEC). Reactions from Databento EOD.
| +5.2% |
| 2024-11-12 | -4.6% |
| RA CAPITAL MANAGEMENT, L.P.Director | BUY | $54.6M | view → |
| Francis ChrisSee Remarks | SELL | $500K | view → |
| Vargeese ChandraSee Remarks | SELL | $43K | view → |
| Francis ChrisSee Remarks | SELL | $25K | view → |
| BOLNO PAULPresident and CEO | SELL | $141K | view → |
| Moran KyleChief Financial Officer | SELL | $48K | view → |